Locust Bean Gum for Biopharmaceutical Applica

LBG is utilized in the development of several drug delivery systems such as tablets, capsules, beads, microspheres, gels and polymer films. LBG-based formulations exhibit sustained release patterns and in a few formulations LBG also has mucoadhesive properties. CD Bioparticles now offers Locust Bean Gum to help researchers and scientists overcome the challenges they face in developing delivery systems. CD Bioparticles provides customers with biocompatible drug delivery systems, including a variety of biodegradable polymers such as Dextrans, Chitosans, Deparins, and Alginates. These polymers help researchers overcome a variety of obstacles such as lengthy chemical synthesis and purification, limited material selection for additive manufacturing precision medicine, unpredictable or uncontrollable degradation rates of drug-carrying cargoes, and denaturation of biomolecules during binding. Together with these biodegradable polymers, this new line of Locust Bean Gum will provide customers with a wide range of benefits, including broad coverage of the functionalized biomolecules useful for customized conjugation, modification, and crosslinking applications, precise formulation of the polymer components to control the degradation time for different drug delivery and bio-graft applications, and diverse solidification of the materials for additive manufacturing of precision medicine. For more information about CD Bioparticles' new line of Locust Bean Gum, please visit https://www.cd-bioparticles.net/locust-bean-gum. About CD Bioparticles CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery.